| abstract |
【Task】 To provide a composition for use as an adjunct therapeutic agent in an anticancer chemotherapeutic agent, a therapeutic agent for acquired immunodeficiency syndrome, and a therapeutic agent for leukemia. SOLUTION: Lactobacillus reuteri LRE03 strain DSM23879, which can potently stimulate the production of the inflammatory cytokine (Th1) interferon (INF) -γ, which exhibits significant antiviral and / or antibacterial activity, and / or significant antiviral Provided is a composition comprising or preferably a mixture of Lactobacillus salivarius LS06 strain DSM26037 capable of strongly stimulating the production of active and / or antiviral dendritic cells. In addition, a composition comprising one or more of the following compounds is provided: a bacterial strain capable of producing the bacterial extracellular polysaccharide EPS when ingested; and / or tara gum and the like. Plant polysaccharides; and / or Candelabra aloe (Aloe arborescens) gels; and / or gelling agents such as sodium alginate, and / or highly biologically available that are incorporated into intermittently sterilized bacterial cells. zinc. [Selection diagram] None |